Sign In to Follow Application
View All Documents & Correspondence

A Composition Comprising Of A Xanthonoid And 7, 8, 4 Trihydroxyisoflavone And Uses Thereof

Abstract: The present disclosure relates to a composition comprising of mangiferin and 7,8,4-trihydroxyisoflavone for increased cellular uptake of glucose, and increased expression of GLUT4. The present disclosure also provides for formulations comprising the same, method of increasing cellular glucose uptake, and expression of GLUT4 by a composition or formulation as mentioned herein.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
26 September 2013
Publication Number
32/2015
Publication Type
INA
Invention Field
PHARMACEUTICALS
Status
Email
lsmds@lakshmisri.com
Parent Application

Applicants

ITC LIMITED
ITC-LIFE SCIENCE AND TECHNOLOGY CENTER #3. 1st Main, Peenya industrial area, Phase-1, Bangalore 560 058

Inventors

1. DEVAN, Sabarinathan
LIFE SCIENCE AND TECHNOLOGY CENTER, ITC Ltd, 1st Main, Peenya industrial area, Phase-1, Bangalore 560 058
2. FATIMA, Humaira
LIFE SCIENCE AND TECHNOLOGY CENTER, ITC Ltd, 1st Main, Peenya industrial area, Phase-1, Bangalore 560 058
3. DIXIT, Ajay Kumar
LIFE SCIENCE AND TECHNOLOGY CENTER, ITC Ltd, 1st Main, Peenya industrial area, Phase-1, Bangalore 560 058
4. KS, NandaKumar
LIFE SCIENCE AND TECHNOLOGY CENTER, ITC Ltd, 1st Main, Peenya industrial area, Phase-1, Bangalore 560 058
5. CHITTUR, Lakshmanan Chandrasekharan
LIFE SCIENCE AND TECHNOLOGY CENTER, ITC Ltd, 1st Main, Peenya industrial area, Phase-1, Bangalore 560 058
6. RADHAKRISHNAN, Yashwanth
LIFE SCIENCE AND TECHNOLOGY CENTER, ITC Ltd, 1st Main, Peenya industrial area, Phase-1, Bangalore 560 058

Specification

DESC:A COMPOSITION COMPRISING OF MANGIFERIN AND 7,8,4-TRIHYDROXYISOFLAVONE AND USES THEREOF ,CLAIMS:1. A composition comprising:
a. mangiferin; and
b. 7,8,4-trihydroxyisoflavone.
2. The composition as claimed in claim 1, wherein said composition increases cellular glucose uptake.
3. The composition as claimed in claim 1, wherein said composition increases expression of GLUT4 transcripts.
4. The composition as claimed in claim 1, wherein the mangiferin to 7,8,4-trihydroxyisoflavone w/w ratio in said composition is 6:1-1:1.
5. The composition as claimed in claim 4, wherein the mangiferin to 7,8,4-trihydroxyisoflavone w/w ratio in said composition is 5:1-1.25:1.
6. A formulation comprising a composition as claimed in claim 1.
7. The formulation as claimed in claim 6, further comprising of suitable carriers, diluents, and excipients.
8. The formulation as claimed in claim 6, wherein the mangiferin to 7,8,4-trihydroxyisoflavone w/w ratio in said formulation is 6:1-1:1.
9. The formulation as claimed in claim 8, wherein the mangiferin to 7,8,4-trihydroxyisoflavone w/w ratio in said formulation is 5:1-1.25:1.
10. A method of increasing cellular glucose uptake, said method comprising:
a. obtaining a composition as claimed in claim 1 or a formulation as claimed in claim 6; and
b. contacting said composition or formulation obtained from step (a) with a cell with extracellular glucose.
11. A method of increasing GLUT4 expression, said method comprising:
a. obtaining a composition as claimed in claim 1 or a formulation as claimed in claim 6; and
b. contacting said composition or formulation obtained from step (a) with a cell.
12. A method of preparing a composition as claimed in claim 1 or a formulation as claimed in claim 6.

Documents

Orders

Section Controller Decision Date

Application Documents

# Name Date
1 4378-CHE-2013-US(14)-HearingNotice-(HearingDate-18-08-2021).pdf 2021-10-17
1 SPEC IN.pdf 2013-10-08
2 FORM 3.pdf 2013-10-08
2 4378-CHE-2013-Correspondence to notify the Controller [16-08-2021(online)].pdf 2021-08-16
3 FIGURES IN.pdf 2013-10-08
3 4378-CHE-2013-CLAIMS [06-03-2020(online)].pdf 2020-03-06
4 4378-CHE-2013 CORRESPONDENCE OTHERS 20-11-2013.pdf 2013-11-20
4 4378-CHE-2013-FER_SER_REPLY [06-03-2020(online)].pdf 2020-03-06
5 4378-CHE-2013-FER.pdf 2019-09-06
5 4378-CHE-2013 POWER OF ATTORNEY 20-11-2013.pdf 2013-11-20
6 Form 18 [20-01-2017(online)].pdf 2017-01-20
6 4378-CHE-2013 FORM-1 20-11-2013.pdf 2013-11-20
7 SPEC FOR FILING.pdf 2014-09-17
7 FIG IN.pdf 2014-09-17
8 SPEC FOR FILING.pdf 2014-09-17
8 FIG IN.pdf 2014-09-17
9 Form 18 [20-01-2017(online)].pdf 2017-01-20
9 4378-CHE-2013 FORM-1 20-11-2013.pdf 2013-11-20
10 4378-CHE-2013 POWER OF ATTORNEY 20-11-2013.pdf 2013-11-20
10 4378-CHE-2013-FER.pdf 2019-09-06
11 4378-CHE-2013 CORRESPONDENCE OTHERS 20-11-2013.pdf 2013-11-20
11 4378-CHE-2013-FER_SER_REPLY [06-03-2020(online)].pdf 2020-03-06
12 FIGURES IN.pdf 2013-10-08
12 4378-CHE-2013-CLAIMS [06-03-2020(online)].pdf 2020-03-06
13 FORM 3.pdf 2013-10-08
13 4378-CHE-2013-Correspondence to notify the Controller [16-08-2021(online)].pdf 2021-08-16
14 SPEC IN.pdf 2013-10-08
14 4378-CHE-2013-US(14)-HearingNotice-(HearingDate-18-08-2021).pdf 2021-10-17

Search Strategy

1 search_04-09-2019.pdf